KENTUCKY NEPHROLOGY RESEARCH TRUST… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

SIGRUN LEONHARDT PHD

Phone

8598792113

Tax Period

2023-01-01 to 2023-12-31

KENTUCKY NEPHROLOGY RESEARCH TRUST INC, founded in 2001, is a community nonprofit in the Health Care sector that reported $1.2M in total revenue in fiscal year 2023. Revenue surged 61% from the prior year, signaling strong growth momentum. The organization ran a surplus of $399K, a strong 35% operating margin.

Mission

OPERATE CLINICS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE NOT YET ON HEMODIALYSIS, AND PROVIDE FUNDING FOR RESEARCH ON RENAL AND BONE DISEASE.

Program Service Accomplishments

Program 1

Expenses: $423,715 Revenue: $466,817

KENTUCKY NEPHROLOGY RESEARCH TRUST, INC. ("KNRT") PROVIDES EDUCATION AND SUPPORT TO PATIENTS WITH CHRONIC KIDNEY DISEASE, PRIOR TO PROGRESSING TO END-STAGE RENAL DISEASE WITH DIALYSIS. THE PROGRAM...

KENTUCKY NEPHROLOGY RESEARCH TRUST, INC. ("KNRT") PROVIDES EDUCATION AND SUPPORT TO PATIENTS WITH CHRONIC KIDNEY DISEASE, PRIOR TO PROGRESSING TO END-STAGE RENAL DISEASE WITH DIALYSIS. THE PROGRAM ASSISTS APPROXIMATELY 826 PATIENTS SUFFERING FROM RENAL DISEASE.

Program 2

Expenses: $215,326

KENTUCKY NEPHROLOGY RESEARCH TRUST, INC. ("KNRT") PROVIDES GRANTS TO SUPPORT THE RESEARCH, EDUCATION, PREVENTION, AND CURE OF DISEASES OF THE KIDNEY AND RELATED ILLNESSES. THIS SUPPORT IS BEING...

KENTUCKY NEPHROLOGY RESEARCH TRUST, INC. ("KNRT") PROVIDES GRANTS TO SUPPORT THE RESEARCH, EDUCATION, PREVENTION, AND CURE OF DISEASES OF THE KIDNEY AND RELATED ILLNESSES. THIS SUPPORT IS BEING EXPANDED TO INCLUDE COLLABORATION BETWEEN THE UNIVERSITY OF KENTUCKY AND THE UNIVERSITY OF FLORIDA RESEARCH INTO THE EFFECTS KIDNEY AND BONE HEALTH ON AGING, AND THE HEALTHY AGING OF PATIENTS WITH RENAL DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $240,015

Program Service Revenue $466,817

Investment Income $372,562

Other Revenue $72,642

TOTAL REVENUE $1,152,036

Expense Breakdown

Grants Paid $215,326

Salaries & Benefits $100,345

Fundraising Expenses $0

Program Expenses $639,041

Other Expenses $437,275

TOTAL EXPENSES $752,946

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,152,036	$717,696	+0.6%
Expenses	$752,946	$818,325	-0.1%
Net Income	$399,090	$-100,629	-5.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$46,643

Total Directors

$49,643

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RON BLAKE	PRESIDENT	1.00	Director	$1,000	$0	$1,000
SIGRUN LEONHARDT	DIRECTOR/SECRETARY	20.00	Officer Director	$46,643	$0	$46,643
MARK KORONA	DIRECTOR	1.00	Director	$1,000	$0	$1,000
SHANE A WARE	DIRECTOR	1.00	Director	$1,000	$0	$1,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,152,036	$752,946	$3,754,874	$399,090
2022	$717,696	$818,325	$3,256,797	$-100,629
2021	$786,778	$1,003,162	$3,960,344	$-216,384
2020	$743,474	$1,027,443	$3,589,947	$-283,969
2019	$744,888	$863,353	$3,559,246	$-118,465
2018	$1,172,541	$870,063	$3,129,550	$302,478

KENTUCKY NEPHROLOGY RESEARCH TRUST INC